Back to Search
Start Over
A diagnostic challenge of KIT p.V559D and BRAF p.G469A mutations in a paragastric mass.
- Source :
-
The oncologist [Oncologist] 2024 Jun 17. Date of Electronic Publication: 2024 Jun 17. - Publication Year :
- 2024
- Publisher :
- Ahead of Print
-
Abstract
- A patient with gastrointestinal stroma tumor (GIST) and KIT p.V559D and BRAF p.G469A alterations was referred to our institutional molecular tumor board (MTB) to discuss therapeutic implications. The patient had been diagnosed with B-cell chronic lymphocytic leukemia (CLL) years prior to the MTB presentation. GIST had been diagnosed 1 month earlier. After structured clinical annotation of the molecular alterations and interdisciplinary discussion, we considered BRAF/KIT co-mutation unlikely in a treatment-naïve GIST. Discordant variant allele frequencies furthermore suggested a second malignancy. NGS of a CLL sample revealed the identical class 2 BRAF alteration, thus supporting admixture of CLL cells in the paragastric mass, leading to the detection of 2 alterations. Following the MTB recommendation, the patient received imatinib and had a radiographic response. Structured annotation and interdisciplinary discussion in specialized tumor boards facilitate the clinical management of complex molecular findings. Coexisting malignancies and clonal hematopoiesis warrant consideration in case of complex and uncommon molecular findings.<br /> (© The Author(s) 2024. Published by Oxford University Press.)
Details
- Language :
- English
- ISSN :
- 1549-490X
- Database :
- MEDLINE
- Journal :
- The oncologist
- Publication Type :
- Academic Journal
- Accession number :
- 38886160
- Full Text :
- https://doi.org/10.1093/oncolo/oyae137